论文信息 - Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53 - 字舞流文

Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53

G. Naik | G. Shapiro | F. Meric-Bernstam | J. Infante | D. Hong | L. Walensky | D. A. Annis | S. Goel | M. Aivado | G. Falchook | T. Bauer | G. Rabinowits | V. Vukovic | R. Conry | Judy S. Wang | U. Steidl | V. Guerlavais | M. Patel | K. Chung | M. Saleh